Gspt2 - G1 to S phase transition 2 Gene
Species: Mus musculus
Gene Type: protein coding
Gene ID: 14853
Summary
Predicted to enable GTPase activity and translation release factor activity. Predicted to be involved in cytoplasmic translational termination. Predicted to act upstream of or within nuclear-transcribed mRNA catabolic process, nonsense-mediated decay. Predicted to be located in cytoplasm. Predicted to be part of translation release factor complex. Is expressed in adrenal gland; genitourinary system; intestine; and spinal cord. Orthologous to human GSPT2 (G1 to S phase transition 2). [provided by Alliance of Genome Resources, Apr 2022]
Gspt2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_008179.2 | NP_032205.2 | eukaryotic peptide chain release factor GTP-binding subunit ERF3B |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
eukaryotic peptide chain release factor GTP-binding subunit ERF3B |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-150259 | MDEG-541 | Degrader | 98.68% | Unkown |
| HY-161101 | MG degrader 1 | Degrader | 99.30% | Unkown |
| HY-177744 | GSPT2 degrader-1 | / | Unkown | |
| HY-RS05869 | GSPT2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-177777 | FL2-14 | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service